Little Barry got an F-. In fact, I think his grade was a big fat zero.
Hopefully this will be an entertaining lesson in Economics
Little Barry got an F-. In fact, I think his grade was a big fat zero.
Top 10 Most Recent News Articles
Regeneron: Investors Face Class Action Over Study Flaws
Regeneron Investors Grit Teeth Amid Lawsuit Drama The gloves are off in the pharmaceutical battleground, folks. Investors who thought they were riding the big wave with Regeneron Pharmaceuticals (NASDAQ: REGN) are now staring down the barrel of a class action lawsuit. It seems the company’s been caught in a storm of legal action following allegations of misleading...
Continue Reading
Connected Retail Security: Rising Risks and Fragmented Roles
Cyber Threats in the Connected Retail Landscape The retail world isn't what it used to be. Walk into a store today, and you're greeted not just by products but a web of interconnected systems screaming for attention. Sure, you've got your old-school POS systems humming along, but they're just one brittle cog in a rattling machine of IoT devices, cloud platforms, and...
Continue Reading
King Risk Partners Expands Mid-Atlantic Presence Boldly
King Risk Partners Grows with New Jersey Acquisition You don't get far in the insurance game without making some bold moves, and King Risk Partners just made a big one—sweeping into New Jersey. They've snagged Conover Beyer Associates Insurance, a firm that's been around longer than some European countries. It's not every day you buy a piece of history, but that's...
Continue Reading
Cheetah Mobile Q2 2026 Results: What's on the Horizon?
Anticipation Builds for Cheetah Mobile's Q2 Results Nine rounds into the slugfest that is the 2026 market, we've got another round approaching—Cheetah Mobile is set to unveil its second quarter numbers on September 11th. This isn't some sleepy, run-of-the-mill report either; NYSE:CMCM is a player with skin in the IT game, and commentators are eyeing the clock with...
Continue Reading
Long Island's JCC Boosted by Manes Family Legacy
Unpacking a Monumental Gift to Long Island's Jewish Community Right out of the gate, this is a big one for the folks over at the Mid Island Y JCC in Plainview, Long Island. They've just hit the jackpot with a historic naming gift, transforming the place into the Manes JCC. Now, why does this matter to anyone keeping tabs on the nonprofit world? Because gifts like these...
Continue Reading
Missouri American Water's $34.5M Neosho Acquisition Outline
Missouri American Water Expands in Neosho, Missouri Well, buckle up because Missouri American Water just sealed the deal to take over Neosho's water and wastewater systems. This acquisition cost them a cool $34.5 million and is bringing 5,400 water and another 5,400 wastewater customers into the fold. Plus, they're welcoming onboard 25 local workers who've been in the...
Continue Reading
Jim Morey Joins Pickleman's to Drive Expansion
Jim Morey: Catalyst for Pickleman's Ambitious Dreams You ever heard of a sandwich joint ready to take on the big leagues? Because that's just what Pickleman's Gourmet Café is banking on with their latest move—tapping none other than Jim Morey for their executive advisory board. And let me tell ya, this ain't some run-of-the-mill hire. We're talking about a guy who's...
Continue Reading
Stronghold's Unfulfilled Promise May Cost Coachella Millions
Coachella's Taxpayer Gamble City of Coachella decided to pull the plug on a deal that could've kept wallets fuller around here. Stronghold Power Systems officials say their shot at leading the municipal utility project got snagged by some bureaucratic red tape or maybe something else. Procurement Process: Two-year-long selection. Investment by Stronghold: $8 million of...
Continue Reading
LaserPecker Debuts U1: Innovations in UV Laser Engraving
An Eye on the Future with LaserPecker's U1 This ain't your typical innovation announcement. LaserPecker is shifting the sands with their latest release, the U1, at IFA 2026 in Berlin. For anyone sick of struggling with transparent materials like glass and crystal, this thing promises to be a game-changer, boasting cutting-edge technology in UV laser engraving. While...
Continue Reading
Smithfield's Foreign Lobbying Interests Unveiled Amid Uproar
A Behind-the-Scenes Drama Over Lobbying Disclosure Something's fishy beneath the surface of Smithfield Foods' recent lobbying debacle. The Center for Responsible Food Business (CRFB) has turned the spotlight on some shady practices, and folks, it ain't pretty. Smithfield's lobbyists had been ducking disclosure rules apparently meant to keep track of foreign influence. Who...
Continue ReadingTop 5 Most Recently Viewed Articles
Market Movements Indicate Potential for Uber Technologies Growth
Understanding Recent Market Movements for Uber Technologies Investors with substantial capital are showing a growing optimism towards Uber Technologies (NYSE: UBER). The trends observed in the options market suggest noteworthy developments that could influence future performance. Recent activities hint at a possible shift in the company’s trajectory, with many players...
Continue Reading
Investors Eye Class Action Suit Against Telix Pharmaceuticals
Class Action Lawsuit Filed Against Telix Pharmaceuticals In recent legal developments, a class action lawsuit has been initiated on behalf of investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX). This lawsuit concerns the company's securities transactions that occurred between specific dates. If you have purchased any securities of Telix during this specified timeframe,...
Continue Reading
Mid-Year Crypto Performance: Bitcoin Leads While Others Struggle
Overview of the Crypto Market in 2025 The first half of 2025 has seen a substantial shift in the cryptocurrency landscape. Despite a total market capitalization exceeding $3 trillion, only a handful of cryptocurrencies have shown significant gains. This fragmentation underlines the varied performance across different assets within the market. Bitcoin and Fartcoin Take the...
Continue Reading
Karyopharm's Phase 3 Trial: A Glimpse into Myelofibrosis
Karyopharm's Upcoming Investor Call: A Big Moment There's a buzz in the air, folks. Karyopharm Therapeutics, the brain behind some nifty cancer treatments, is gearing up for an investor shindig. Slated for June 2, 2026, the company aims to lay out the nitty-gritty of its Phase 3 SENTRY trial at 2:00 p.m. ET. With Dr. John Mascarenhas, a heavyweight in the myelofibrosis...
Continue Reading
Continued Growth and Cost Cuts at Hooker Furnishings Q1 Results
Overview of Operating Results at Hooker Furnishings Hooker Furnishings Corporation (NASDAQ: HOFT) has reported noteworthy developments in its operating results for the first quarter of fiscal 2026. The company is recognized for its long-standing presence and commitment to producing exquisite home furnishings. By implementing various cost-saving initiatives, Hooker has...
Continue Reading